Evoke Pharma, Inc.
EVOK News Today: Stay Updated with the Latest Evoke Pharma, Inc. News in Real Time
Find EVOK news now at Meyka AI. Stay informed with the latest Evoke Pharma, Inc. stocks updates, including price news, market analysis, and expert insights.
Hercules Capital Posts Record $1.81B in Q1 Debt and Equity Commitments
Hercules Capital reported a record $1.81 billion in debt and equity commitments in Q1 2026, marking its strongest quarterly performance to date. This is a sharp rise from about $1.02 billion in Q1 2025, showing growing demand for venture debt. The funding supported 28 companies, including both new and existing clients. This surge comes at…
Mark Gibbens’ Top Tech Stocks to Watch: Palantir, Nvidia, & JPMorgan
Global tech stocks saw sharp swings in early 2026, with AI leaders correcting after a strong 2024-2025 rally. As of March 2026, valuations across major tech firms have cooled, creating fresh entry points for investors. Amid this shift, top CIO Mark Gibbens has highlighted a focused list of stocks that could benefit from the next…
Down 50% to C$0.005: BRAS.CN Nordique Resources Inc. (CNQ) 06 Apr 2026, key risk
BRAS.CN stock down 50% to C$0.005 on 06 Apr 2026; we examine valuation, liquidity and Meyka forecast
6597.T stock up 43% to JPY 3000 on JPX close 06 Apr 2026: strong volume may sustain gains
6597.T stock jumps 43% to JPY 3000 on JPX close 06 Apr 2026; volume surge and fundamentals examined
€0.05 intraday low: VisionSys AI (0T8B.F, XETRA) 06 Apr 2026 watch rebound
Intraday update for 0T8B.F stock: €0.05 low, heavy volume; oversold bounce setup and Meyka AI forecast
Pre-market $452.07: ISRG Intuitive Surgical NASDAQ 06 Apr 2026: AI +29.53%
Pre-market ISRG stock update: price $452.07, PE 57.37, Meyka AI forecast +29.53% annual upside
NGD.TO New Gold (TSX) C$12.16 pre-market Apr 06 2026: heavy volume, watch momentum
NGD.TO stock pre-market at C$12.16 on Apr 06 2026; volume surging, EPS C$1.48, PE 8.22, model forecasts C$20.11
Aurobindo Pharma Announces Share Buyback at ₹1,475 – Details on Size, Record Date, and More
Aurobindo Pharma has just taken a bold step that grabbed investor attention on April 6, 2026. The Hyderabad‑based pharmaceutical major’s board approved a share buyback at ₹1,475 per share, marking one of the most talked‑about corporate actions in the Indian markets this week. This plan, valued at ₹800 crore, signals confidence from management and offers…
GNRSU stock drops to $0.000001 on 06 Apr 2026: low liquidity raises risk
GNRSU stock falls to $0.000001 on 06 Apr 2026; analysis, Meyka AI grade B, liquidity risks and forecast